5I8A:
reference: Potent, selective and orally bioavailable leucine-rich repeat kinase 2 (LRRK2) inhibitors., Greshock TJ, Sanders JM, Drolet RE, Rajapakse HA, Chang RK, Kim B, Rada VL, Tiscia HE, Su H, Lai MT, Sur SM, Sanchez RI, Bilodeau MT, Renger JJ, Kern JT, McCauley JA, Bioorg Med Chem Lett. 2016 Jun 1;26(11):2631-5. doi: 10.1016/j.bmcl.2016.04.021. , Epub 2016 Apr 9. PMID: 27106707

This OCA Structure page
uses Jmol, developed by the Jmol Development Team (documentation).